Awards and Grant Winners, Member and FSCAI Inductions, and MSCAI Ceremony

J. Dawn Dawn Abbott, MD, MSCAI

Collaborative Breakfast Session: Calcium - RotaCUT

Calcium - RotaCUT

Mohamed Nosair, M.D., Ph.D.

Discussion

Collaborative Breakfast Session: STEMI-DTU Trial: Analysis of Results and Clinical Relevance

STEMI-DTU Trial: Analysis of Results and Clinical Relevance

Navin K. Kapur, M.D., FSCAI

Discussion

Collaborative Session (HLS) Early and Rapid Reduction in LDL-C Following the Cath Lab: The Era of Interventional Lipidology

Kevin Bainey, MD

Collaborative Session - Choosing the Optimal DES in Complex Cases: What Matters Most

Raja Hatem, M.D.

Discussion

Collaborative Session: Shocking Calcium – Case-Based Lessons from the Toughest Lesions

Shocking Calcium: Case-Based Lessons from the Toughest Lesions

Sanjit S. Jolly, M.D.

Controversies in Cardiovascular Interventions Workshop

Controversies Case

Brian Courtney, MD

Controversies Case

Steven Miner

Controversies Case

Aun-Yeong Chong, M.D.

Coronary Access in TAVI Patients?

Maneesh Sud, MD, PhD

Crack, Cut, or Shave: Update on Calcium Modification

Ram Vijayaraghavan, MD

Discussion

Drug-Coated Balloons: Leave no Metal Behind

Introductory Remarks

The Science of DCBs: How to Use

Said Ashraf, MD, FSCAI

Discussion

For What Types of De Novo Lesions Should We Consider DCB?

Samer Mansour, M.D.

Disruptive Technology: Time to Rethink how we Perform PCI – An 80:20 DCB to DES Ratio Makes Sense

Antonio Colombo, M.D., MSCAI

Great for Niche Indications but Currently Overhyped – A 20:80 DCB to DES Ratio Should Suffice –

Manish A. Parikh, M.D., FSCAI

Discussion

Essential Techniques for CTO PCI

From Soft to Stiff: The Art and Science of Wire Escalation in CTOs

Arasi Maran, M.D., FSCAI

Escalating Wires for Controlled Re-entry: Optimizing ADR Success

Asaad Nakhle, MD, FSCAI

Discussion: Are Wire Skills Important? Why has There Been a Reduction in ADR?

From Entry to Exit: A Structured Approach to STAR

Kate Kearney, M.D., FSCAI

Reverse CART in CTO PCI: Bridging Antegrade and Retrograde Strategies

Khaldoon Alaswad, M.D., FSCAI

Discussion: Goals of antegrade dissection and re-entry (ADR) strategies

Hildner Lecture: How Vascular Biology and Quantum Dynamics Drove A Revolution in Cardiovascular Sciences & Intervention

Hildner Lecture Introductory Remarks

Sahil A. Parikh, MD, FSCAI

Hildner Lecture: How Vascular Biology and Quantum Dynamics Drove A Revolution in Cardiovascular Sciences & Intervention

Elazer R. Edelman, MD, Ph.D.

Joint Session: Coronary Artery Disease in TAVI Patients, to Revascularize or Not? Perspectives?

Coronary Artery Disease in TAVI Patients, to Revascularize or Not? Perspectives?

David A. Wood, M.D.

Discussion

Joint Session: Pivotal Structural & Coronary Trials Driving Practice Change in 2025

Pivotal Coronary Trials Driving Practice Change in 2025

Samer Mansour, M.D.

Pivotal Structural Trials Driving Practice Change in 2025

Andrew Czarnecki, MD, MSc

Discussion

Keynote Presentation with Martin B. Leon, MD

Keynote Speaker Introductory Remarks

Sahil A. Parikh, MD, FSCAI

Medical Device Development: A Journey to Transform Patient’s Lives

Martin B. Leon, M.D.

Late Breaking Clinical Trials

Sirolimus Eluting Balloons for Patients with Acute Coronary Syndrome – Evidence from the SELUTION DeNovo Trial

Andy Ladwiniec, MD

Discussion

Antonio Colombo, M.D., MSCAI

AltaValve Early Feasibility Study: One-Year Outcomes with Atrial Fixation Transcatheter Mitral Valve Replacement

Konstantinos Voudris, M.D., Ph.D., FSCAI

Discussion

David J. Cohen, M.D., FSCAI

PROMISE III: 6-Month Clinical and Quality of Life Outcomes in CLTI Patients Treated with Transcatheter Arterialization of the Deep Veins

Mehdi H. Shishehbor, D.O., MPH, PhD, FSCAI

Discussion

Sahil A. Parikh, MD, FSCAI

Can Escalation Reduce Acute myocardial infarction Mortality In Cardiogenic Shock (CERAMICS)

Babar B Basir, DO, FSCAI

Trial Update: Clinically Important Subgroups from STEMI D2U

Norman Mangner

Discussion

Kate Kearney, M.D., FSCAI

Low Contrast PCI for the Beginner

Ali Hillani, MD

Discussion

Management of Cardiogenic Shock in Canada – Standardizing Canadian Practice

Management of Cardiogenic Shock in Canada - Standardizing Canadian Practice

Ayaaz K. Sachedina, MD, FRCPC

Discussion

My Most Challenging Complication Case

Case Presentation

Micha F Dorsch, M.D., Ph.D.

Case Presentation

Ali Pourdjabbar, M.D.

Case Presentation

Vincent Spagnoli

Case Complication

Roger Philipp

Ostial Lesions - Tips and Tricks

Ali Hillani, MD

Discussion

Presidential Address by J. Dawn Abbott, MD, MSCAI, President 2026-2027

Transition of Leadership and Presidential Address by J. Dawn Abbott, MSCAI, President 2026-2027

J. Dawn Dawn Abbott, MD, MSCAI

Stent Failure in the Canadian Context

Dr. Mohammad Almutawa, M.D.

Discussion

Trapped And Stuck Gear

Allison Barbara Hall, M.D., FSCAI

Discussion

Update in Acute MI Cardiogenic Shock Management

Introductory Remarks

Emerging Evidence: Key Updates from Recent and Ongoing Trials

Holger Thiele, MD

Rethinking Cardiogenic Shock: Innovative Treatment Paradigms

Sanjog Kalra, M.D.

Discussion: Translating Evidence Into Practice

Keeping them Alive After Canulation: How Interventionalists Are Changing Shock Care

Ann Gage, M.D.

ECMO: Out of the OR and Into the Cath Lab

Babar B Basir, DO, FSCAI

ECMO Bootcamp: What Every Operator Needs to Know

Allison G. Dupont, M.D., FSCAI

Discussion: Establishing ECMO in my System

Welcome to SCAI 2026 from Program Chair, Sahil Parikh, MD, FSCAI and Presidential Address by Srihari Naidu, MD, MSCAI, SCAI President 2025-2026, Award Presentations

Welcome to SCAI 2026!

Sahil A. Parikh, MD, FSCAI

Presidential Address

Srihari S. Naidu, MD, MSCAI

CAIC Remarks

Kevin Bainey, MD

SCAI Award Presentations: Helping Hearts Lifetime Service Award

Srihari S. Naidu, MD, MSCAI

2026 Scientific Sessions

CAIC-ACCI Summit: Coronary